Literature DB >> 10716480

Exercise-induced U-wave alterations as a marker of well-developed and well-functioning collateral vessels in patients with effort angina.

K Miwa1, K Nakagawa, T Hirai, H Inoue.   

Abstract

OBJECTIVES: We sought to determine whether exercise-induced U-wave alterations are observed in association with well-developed and well-functioning collateral vessels.
BACKGROUND: Although exercise-induced electrocardiographic (ECG) U-wave alterations including negative and prominent U waves have been established as a marker of significant or critical narrowing of a major coronary artery, the relation between this finding and the degree of collateral development has not yet been determined.
METHODS: Patients with stable effort angina were divided into two groups according to the presence (group A, n = 46) or absence (group B, n = 79) of exercise-induced either negative or prominent U waves in the precordial leads; the clinical profiles, coronary angiographic findings and also ischemic status during 60 s of coronary balloon occlusion were compared between the two groups.
RESULTS: The incidence of severe angina (CCS [Canadian Cardiovascular Society] class III or IV) was higher (p < 0.05) in group A (52%) than in group B (32%) patients. Good collateral vessels (Rentrop grade 2 or 3) into the perfusion territory of the culprit vessel were observed more frequently (p < 0.05) in group A (70%) than in group B (43%) patients. Coronary balloon angioplasty was carried out in 23 patients of group A and 40 patients of group B. Both ischemic ST changes (52% vs. 85%) and angina (57% vs. 80%) during balloon inflation were less (p < 0.05) frequently observed in group A than in group B. The incidence of no apparent myocardial ischemia with ST deviation or angina during the balloon inflation was higher (p < 0.05) in group A (39%) than in group B (10%) patients. In the prediction of the absence of myocardial ischemia during balloon inflation by the presence of exercise-induced U-wave alterations, the sensitivity was 69% (9/13) and the specificity was 72% (36/50) in the study patients.
CONCLUSIONS: Exercise-induced U-wave alterations are a marker for well-developed collateral circulation in patients with stable but severe effort angina. This finding is also highly predictive of the absence of myocardial ischemia during transient coronary balloon occlusion and possibly of low-risk for development of acute myocardial infarction or hemodynamic instability upon abrupt closure of the culprit coronary artery.

Entities:  

Mesh:

Year:  2000        PMID: 10716480     DOI: 10.1016/s0735-1097(99)00394-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  When u say "U Waves," what do u mean?

Authors:  Sami Viskin; David Zelster; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2004-02       Impact factor: 1.976

2.  Discordant U waves in the setting of hyperkalaemia.

Authors:  Lovely Chhabra; David H Spodick
Journal:  BMJ Case Rep       Date:  2013-07-04

3.  U wave variability in the surface ECG.

Authors:  Piotr Kukla; Adrian Baranchuk; Marek Jastrzębski; Leszek Bryniarski
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-21       Impact factor: 1.468

Review 4.  The negative U wave: a pathogenetic enigma but a useful, often overlooked bedside diagnostic and prognostic clue in ischemic heart disease.

Authors:  Ernesto Correale; Rossano Battista; Vincenzo Ricciardiello; Angelina Martone
Journal:  Clin Cardiol       Date:  2004-12       Impact factor: 2.882

Review 5.  Exercise Test for Patients with Long QT Syndrome.

Authors:  Cheng-Han Chan; Yu-Feng Hu; Pei-Fen Chen; I-Chien Wu; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

6.  U wave: an important noninvasive electrocardiographic diagnostic marker.

Authors:  M P Girish; Mohit Dayal Gupta; Saibal Mukhopadhyay; Jamal Yusuf; T N Sunil Roy; Vijay Trehan
Journal:  Indian Pacing Electrophysiol J       Date:  2005-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.